Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis

Heart Rhythm

Volumn 11, Issue 10, 2014, Pages 1752-1759

  Chao, Tze Fan ^a,b   Liu, Chia Jen ^a,b   Wang, Kang Ling ^a,b   Lin, Yenn Jiang ^a,b   Chang, Shih Lin ^a,b   Lo, Li Wei ^a,b   Hu, Yu Feng ^a,b   Tuan, Ta Chuan ^a,b   Chung, Fa Po ^a,b   Liao, Jo Nan ^a,b   Chen, Tzeng Ji ^a   Lip, Gregory Y H ^c   Chen, Shih Ann ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Atrial fibrillation; CHA2DS2 VASc score; CHADS2 score; End stagerenal disease; Ischemic stroke

Indexed keywords

AGED; ANTICOAGULATION; ARTICLE; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CHADS2 SCORE; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; DIALYSIS; DISEASE SEVERITY; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INCIDENCE; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; TRANSIENT ISCHEMIC ATTACK; ATRIAL FIBRILLATION; CLINICAL TRIAL; COMPLICATION; HEMODIALYSIS; KIDNEY FAILURE, CHRONIC; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TAIWAN; TRENDS;

ANTICOAGULANT AGENT;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TAIWAN;

EID: 84922750438     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.06.021     Document Type: Article

References (33)

1. R.G. Hart, and J.L. Halperin Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention Ann Intern Med 131 1999 688 695
2. H.P. Mattle Long-term outcome after stroke due to atrial fibrillation Cerebrovasc Dis 16 Suppl 1 2003 3 8
3. S. Genovesi, D. Pogliani, and A. Faini Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients Am J Kidney Dis 46 2005 897 902
4. T.F. Chao, H.M. Tsao, and K. Ambrose Renal dysfunction and the risk of thromboembolic events in patients with atrial fibrillation after catheter ablation: the potential role beyond the CHA(2)DS(2)-VASc score Heart Rhythm 9 2012 1755 1760
5. J.B. Olesen, G.Y. Lip, A.L. Kamper, K. Hommel, L. Kober, D.A. Lane, J. Lindhardsen, G.H. Gislason, and C. Torp-Pedersen Stroke and bleeding in atrial fibrillation with chronic kidney disease N Engl J Med 367 2012 625 635
6. J.P. Piccini, S.R. Stevens, and Y. Chang Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts Circulation 127 2013 224 232
7. Y. Guo, H. Wang, X. Zhao, Y. Zhang, D. Zhang, J. Ma, Y. Wang, and G.Y. Lip Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation Int J Cardiol 168 2013 1502 1508
8. R. Providencia, S. Barra, and L. Paiva Chronic renal disease is associated with stroke and thromboembolism in atrial fibrillation independently from gender Int J Cardiol 168 2013 3106 3107
9. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
10. J.A. Cairns, S. Connolly, S. McMurtry, M. Stephenson, and M. Talajic Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter Can J Cardiol 27 2011 74 90
11. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation Chest 137 2010 263 272
12. A.J. Camm, G.Y. Lip, and R. De Caterina 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association Eur Heart J 33 2012 2719 2747
13. S. Ogawa, K. Aonuma, H.F. Tse, D. Huang, J.L. Huang, J. Kalman, S. Kamakura, M. Nair, D.G. Shin, M. Stiles, W.S. Teo, and T. Yamane The APHRS's 2013 statement on antithrombotic therapy of patients with nonvalvular atrial fibrillation J Arrhythm 29 2013 190 200
14. C.T. January, L.S. Wann, and J.S. Alpert 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 2014 [Epub ahead of print]
15. S.J. Chen, C.J. Liu, T.F. Chao, K.L. Wang, T.J. Chen, P. Chou, F.D. Wang, S.J. Lin, and C.E. Chiang Dental scaling and atrial fibrillation: a nationwide cohort study Int J Cardiol 168 2013 2300 2303
16. L.J. Lin, M.H. Cheng, C.H. Lee, D.C. Wung, C.L. Cheng, and Y.H. Kao Yang Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation: a nationwide descriptive study in Taiwan Clin Ther 30 2008 1726 1736
17. C.H. Chang, Y.C. Lee, C.T. Tsai, S.N. Chang, Y.H. Chung, M.S. Lin, J.W. Lin, and M.S. Lai Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease Atherosclerosis 232 2014 224 230
18. C.L. Cheng, Y.H. Kao, S.J. Lin, C.H. Lee, and M.L. Lai Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan Pharmacoepidemiol Drug Saf 20 2011 236 242
19. C.C. Lin, M.S. Lai, C.Y. Syu, S.C. Chang, and F.Y. Tseng Accuracy of diabetes diagnosis in health insurance claims data in Taiwan J Formos Med Assoc 104 2005 157 163
20. C.Y. Hsieh, C.H. Chen, C.Y. Li, and M.L. Lai Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database J Formos Med Assoc 2013 [Epub ahead of print]
21. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
22. S.L. Seliger, D.L. Gillen, W.T. Longstreth Jr., B. Kestenbaum, and C.O. Stehman-Breen Elevated risk of stroke among patients with end-stage renal disease Kidney Int 64 2003 603 609
23. V. Roldan, F. Marin, S. Manzano-Fernandez, H. Fernandez, P. Gallego, M. Valdes, V. Vicente, and G.Y. Lip Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation? Thromb Haemost 109 2013 956 960
24. S. Apostolakis, Y. Guo, D.A. Lane, H. Buller, and G.Y. Lip Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial Eur Heart J 34 2013 3572 3579
25. F. Yang, D. Chou, P. Schweitzer, and S. Hanon Warfarin in haemodialysis patients with atrial fibrillation: what benefit? Europace 12 2010 1666 1672
26. T.F. Chao, Y.J. Lin, and H.M. Tsao CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation J Am Coll Cardiol 58 2011 2380 2385
27. J.B. Olesen, C. Torp-Pedersen, M.L. Hansen, and G.Y. Lip The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: A nationwide cohort study Thromb Haemost 107 2012 1172 1179
28. M. Coppens, J.W. Eikelboom, R.G. Hart, S. Yusuf, G.Y. Lip, P. Dorian, O. Shestakovska, and S.J. Connolly The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy Eur Heart J 34 2013 170 176
29. S. Juma, B.K. Thomson, C.E. Lok, C.M. Clase, P.G. Blake, and L. Moist Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty BMC Nephrol 14 2013 174
30. M. Shah, M. Avgil Tsadok, C.A. Jackevicius, V. Essebag, M.J. Eisenberg, E. Rahme, K.H. Humphries, J.V. Tu, H. Behlouli, H. Guo, and L. Pilote Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis Circulation 129 2014 1196 1203
31. G.Y. Lip Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk Europace 13 2011 145 148
32. R.G. Hart, L.A. Pearce, R.M. Rothbart, J.H. McAnulty, R.W. Asinger, and J.L. Halperin Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators J Am Coll Cardiol 35 2000 183 187
33. S.H. Hohnloser, D. Pajitnev, J. Pogue, J.S. Healey, M.A. Pfeffer, S. Yusuf, and S.J. Connolly Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy J Am Coll Cardiol 50 2007 2156 2161